FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
Quest Diagnostics (NYSE: DGX) reported Q3 EPS of $3.96, $1.29 better than the analyst estimate of $2.67. Revenue for the quarter came in at $2.77 billion versus the consensus estimate of $2.42 billion.
"We had a strong third quarter, as COVID-19 molecular volumes increased throughout the summer... More

